Linda-Gail Bekker

Linda-Gail Bekker

Director/Board Member at International AIDS Vaccine Initiative, Inc.

49 connections
Health Technology

Profile

Linda-Gail Bekker is currently the Director at the International AIDS Vaccine Initiative, Inc.

Linda-Gail Bekker active positions

CompaniesPositionStart
International AIDS Vaccine Initiative, Inc.
Logo International AIDS Vaccine Initiative, Inc.

International AIDS Vaccine Initiative, Inc.

Pharmaceuticals: MajorHealth Technology

International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.

 Director/Board Member -
All active positions of Linda-Gail Bekker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Linda-Gail Bekker's experience

Connections

49

1st degree connections

1

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies1
International AIDS Vaccine Initiative, Inc.
Logo International AIDS Vaccine Initiative, Inc.

International AIDS Vaccine Initiative, Inc.

Pharmaceuticals: MajorHealth Technology

International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Linda-Gail Bekker